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The body is continuously exposed to a variety of toxins and metabolic waste products 
but is able to rid itself of these by using various detoxification mechanisms such as 
enzymes and transmembrane transporters. A large number of the transporters which 
play an essential role in the detoxification mechanisms are found in the liver, kidney 
and intestines. The largest family of transporters is the Solute Carrier (SLC) 
Superfamily with 255 members in humans. While most SLC transporters are highly 
specialized, a number of these transporters are polyspecific, generalized transporters 
that play a major role in the elimination process. Accordingly, the aim of this research 
programme was to develop novel methodology to enable the study of the interaction of 
drugs and related compounds with these transporters, in a rapid and facile manner.  
 
In the initial studies the application of affinity chromatography was carried out with the 
use of α1-acid glycoprotein (AGP) column to achieve enantioselective separation of the 
drug ketamine and its metabolites. The enantioselective separation of ketamine and 
norketamine from plasma samples was achieved and the assay conducted was sensitive 
and reproducible. Building upon the experience gained in this work on affinity 
chromatography and LC-MS, these useful tools for the determination of chiral drugs in 
biological fluids were also used in the study of drug-protein interactions. With the 
nicotinic acetylcholine receptors it was possible to explore the use of immobilized 
liquid chromatographic stationary phases containing drug transporters in on-line high 
throughput screening (HTS).  
  IThus having demonstrated that a stationary phase containing immobilized membranes 
can be used to identify substrate/inhibitors of an expressed receptor/transporter the next 
and principal phase of the programme was to adapt the methodology to other target 
biopolymers such as P-glycoprotein which over the last decade has been focused upon 
for its role in drug resistance in cancer treatments. In particular liquid chromatographic 
columns containing the drug transporters, P-glycoprotein (Pgp) and human organic 
cation transporter 1 (hOCT1) were prepared, evaluated and exploited. 
  
Initial studies were conducted to confirm the functionality of a stably transfected cell 
line expressing Pgp (Pgp-(+), LCC6/MDR1 cell line) through a comparison with the 
non-transfected cell line (Pgp-(-), LCC6 cell line). 
 
Initially membranes from the Pgp(+) and Pgp(-) cell lines were then immobilized on  
immobilized artificial membranes. However, although the resulting column could 
actively bind the Pgp substrates, strong non-specific interactions with the IAM 
backbone led to large retention times and peak tailing. A more successful approach was 
to immobilize on the surface of open tubular capillaries. Such columns were used to sort 
compounds with or without affinity for Pgp, by comparing the differential retention 
time on the Pgp (+) and Pgp (-) columns.  In this way the non-specific interactions with 
the constituents of the cellular membrane were compensated for. The results from the 
sorting by differential chromatography were compared with the behavior of the same 
compounds in Caco-2 monolayers cultured in 96-well transwell plates, the standard 
method for the determination of substrates for Pgp. A group of 14 compounds 
  IIpreviously characterized as substrates or non-substrates of Pgp were studied using the 
chromatographic and Caco-2 methods.  In the parallel chromatographic screen, the 
value of Ut varied from 0.11 min (nicardipine) to 21.53 min (domperidone).  The ratio 
of the value of the apparent permeability coefficient (Papp) in the basal-to-apical 
direction (PappB–A) to Papp in the apical-to-basal direction (PappA-B), (PappB-A/PappA-B) 
among the same set of compounds ranged from 1.4 (nicardipine) to 45.0 (domperidone). 
In almost every case, when Ut exceeded 0.25 min, the value of PappB-A/PappA-B was 
greater than 2.0, suggesting that the compound was a Pgp substrate. Also there was a 
positive correlation between the two data sets (r
2 = 0.95). It was therefore clear that the 
parallel screening of new pharmaceutical compounds on Pgp(+) and Pgp (-) open 
tubular columns could be interchanged  with the conventional, widely used Caco-2 
model and could be used to pre-screen and identify Pgp substrates and inhibitors, prior 
to moving onto a more expensive and time consuming functional assays to determine 
functional activity. Also the success of these experiments would help to generate 
affinity chromatography models for other transport proteins. 
 
An illustration of this was a study on the human organic cation transporter, hOCT1 
which plays an essential role in the detoxification mechanisms mediating the 
inactivation and excretion of toxins and metabolic waste products. This transport 
protein was immobilized on an IAM based stationary phase, with no significant non-
specific interactions occurring in this cases, and frontal affinity chromatography was 
used to characterize the activity of the immobilized transporter. The data indicated that 
the hOCT1 bound known hOCT1 substrates and the calculated Kd value for the marker 
  IIIligand N-methyl-4-phenylpyridinium (MPP) was 6.06 pM, consistent with previously 
reported Ki values. The previously found enantioselectivity of hOCT1 was confirmed 
here by determining the ratio of the Kd values for the stereoisomers of propranolol (R/S 
= 2.98), atenolol (R/S = 2.11), psuedoephedrine (S/R = 1.53) and verapamil (S/R = 
86.5). The observed differences in the Kd values of the stereoisomers was used to design 
a pharmacophore which identified the different interactions between the 
substrate/inhibitor and hOCT1 to help to explain the enantioselectivity of the hOCT1 
transporter. The pharmacophore contained a hydrophobic region (π-π interaction, or π-
cation interactions), a hydrogen bond donor and an ion pair interaction region. It was 
then expanded to include other ligands and a general approach to the determination of 
whether a compound is a substrate/inhibitor of the hOCT1 was formulated. This general 
approach shows great promise for making a greater contribution in the future for the 
general understanding of drug protein interactions and in particular to the pre-
Development screening of drug candidates. 
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